These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12826151)

  • 21. The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.
    Shiue LH; Couturier J; Lewis DE; Wei C; Ni X; Duvic M
    Photodermatol Photoimmunol Photomed; 2015 Jul; 31(4):184-94. PubMed ID: 25772268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photochemotherapy induces a faster apoptosis of alloreactive activated T cells than of nonalloreactive resting T cells in graft versus host disease.
    Hannani D; Merlin E; Gabert F; Laurin D; Deméocq F; Chaperot L; Kanold J; Plumas J
    Transplantation; 2010 Dec; 90(11):1232-8. PubMed ID: 21268310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
    Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F
    J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications.
    Hackstein H; Misterek J; Nockher A; Reiter A; Bein G; Woessmann W
    Transfusion; 2009 Nov; 49(11):2366-73. PubMed ID: 19903292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of action of extracorporeal photochemotherapy.
    Heshmati F
    Transfus Apher Sci; 2003 Aug; 29(1):61-70. PubMed ID: 12877896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphoma.
    Tsai YC; Schlaepfer T; Ignatova D; Chang YT; Valaperti A; Amarov B; Blanchard G; Pehr K; Vonow-Eisenring M; Urosevic-Maiwald M; Hoetzenecker W; Pascolo S; Iselin C; Fassnacht C; Dimitriou F; Bobrowicz M; Guenova E
    Br J Dermatol; 2023 Oct; 189(5):603-611. PubMed ID: 37409661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The North American experience with photopheresis.
    Zic JA; Miller JL; Stricklin GP; King LE
    Ther Apher; 1999 Feb; 3(1):50-62. PubMed ID: 10079806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD71 surface analysis of T cells: a simple alternative for extracorporeal photopheresis quality control.
    Schwab L; Michel G; Bein G; Hackstein H
    Vox Sang; 2020 Jan; 115(1):81-93. PubMed ID: 31680273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracorporeal photopheresis: from solid organs to face transplantation.
    Hivelin M; Siemionow M; Grimbert P; Lantieri L
    Transpl Immunol; 2009 Jul; 21(3):117-28. PubMed ID: 19409991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simplified extracorporeal photopheresis procedure based on single high-dose ultraviolet A light irradiation shows similar in vitro efficacy.
    Buchele V; Hackstein H
    Transfusion; 2021 Mar; 61(3):883-893. PubMed ID: 33300629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
    Bladon J; Taylor P
    Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracorporeal photopheresis, a therapeutic option for cutaneous T-cell lymphoma and immunological diseases: state of the art.
    Martino M; Fedele R; Cornelio G; Moscato T; Imbalzano L; Ressa G; Massara E; Bresolin G
    Expert Opin Biol Ther; 2012 Aug; 12(8):1017-30. PubMed ID: 22587646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD).
    Rutella S; Valentini CG; Ceccarelli S; Romano MT; Brescia LP; Milano GM; Locatelli F
    Transfus Apher Sci; 2014 Jun; 50(3):340-8. PubMed ID: 24780391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro PUVA treatment triggers calreticulin exposition and HMGB1 release by dying T lymphocytes in GVHD: New insights in extracorporeal photopheresis.
    Coppard C; Hannani D; Humbert M; Gauthier V; Plumas J; Merlin E; Gabert F; Chaperot L
    J Clin Apher; 2019 Aug; 34(4):450-460. PubMed ID: 30860623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of lymphocyte subpopulations by extracorporeal photopheresis in patients with acute graft-versus-host disease or graft rejection.
    Lorenz K; Rommel K; Mani J; Jin N; Hilgendorf I; Ho AD; Freund M; Schmitt M; Schmitt A
    Leuk Lymphoma; 2015 Mar; 56(3):671-5. PubMed ID: 24913503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracorporeal photochemotherapy.
    Maeda A
    J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-world use of extracorporeal photopheresis for patients with cutaneous T-cell lymphoma in the United States: 2010-2015.
    Ling YL; Huang X; Mitri G; Lovelace B; Pham A; Knobler R; Li X; Gao X
    J Dermatolog Treat; 2020 Feb; 31(1):91-98. PubMed ID: 30892982
    [No Abstract]   [Full Text] [Related]  

  • 38. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease.
    Spisek R; Gasova Z; Bartunkova J
    Transfusion; 2006 Jan; 46(1):55-65. PubMed ID: 16398731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas.
    Atta M; Papanicolaou N; Tsirigotis P
    Transfus Apher Sci; 2012 Apr; 46(2):195-202. PubMed ID: 22067605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease.
    Fimiani M; Di Renzo M; Rubegni P
    Br J Dermatol; 2004 Jun; 150(6):1055-60. PubMed ID: 15214889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.